Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhuolin Wu

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Cancer Science|June 17, 2025
Selinexor Reduces the Immunosuppression of Macrophages and Synergizes With CD19 CAR-T Cells Against B-Cell LymphomaWenjing Luo, Jia Xu, Chenggong Li, et al.
Frontiers in Immunology|July 8, 2022
Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic LeukemiaYinqiang Zhang, Fen Zhou, Zhuolin Wu, et al.
Lipids in Health and Disease|September 28, 2024
Rod-shaped mesoporous silica nanoparticles reduce bufalin cardiotoxicity and inhibit colon cancer by blocking lipophagyYibao Fan, Wei Zhang, Zoya Iqbal, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 14, 2025
Artificial Mitochondrial Nanorobots Deliver Energy In Vivo by Oral AdministrationNan Li, Min Zhou, Ziyu Wu, et al.
Yonsei Medical Journal|December 8, 2017
Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger SequencingChaoyue Liang, Zhuolin Wu, Xiaohong Gan, et al.
International Immunopharmacology|June 19, 2024
Identification of key genes and immune infiltration in peripheral blood biomarker analysis of delayed cerebral ischemia: Valproic acid as a potential therapeutic drugZhuolin Wu, Zilin Zhao, Yang Li, et al.
Cancer Medicine|October 22, 2025
BTK Inhibitor Synergizes With CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients With Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic Clinical TrialWenjing Luo, Yinqiang Zhang, Chenggong Li, et al.
Cancer Management and Research|October 6, 2018
An expression signature model to predict lung adenocarcinoma-specific survivalXiaoshun Shi, Haoming Tan, Xiaobing Le, et al.
Frontiers in Molecular Neuroscience|January 28, 2026
Omaveloxolone promotes functional recovery of spinal cord injury by reducing inflammatory response and regulating macrophage polarizationPengtian Zhao, Wenlu Yuan, Jiayi Zhang, et al.
Cytotherapy|April 19, 2023
Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphomaWenjing Luo, Chenggong Li, Jianghua Wu, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cancer Science|June 17, 2025
Selinexor Reduces the Immunosuppression of Macrophages and Synergizes With CD19 CAR-T Cells Against B-Cell LymphomaWenjing Luo, Jia Xu, Chenggong Li, et al.
Frontiers in Immunology|July 8, 2022
Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic LeukemiaYinqiang Zhang, Fen Zhou, Zhuolin Wu, et al.
Lipids in Health and Disease|September 28, 2024
Rod-shaped mesoporous silica nanoparticles reduce bufalin cardiotoxicity and inhibit colon cancer by blocking lipophagyYibao Fan, Wei Zhang, Zoya Iqbal, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 14, 2025
Artificial Mitochondrial Nanorobots Deliver Energy In Vivo by Oral AdministrationNan Li, Min Zhou, Ziyu Wu, et al.
Yonsei Medical Journal|December 8, 2017
Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger SequencingChaoyue Liang, Zhuolin Wu, Xiaohong Gan, et al.
International Immunopharmacology|June 19, 2024
Identification of key genes and immune infiltration in peripheral blood biomarker analysis of delayed cerebral ischemia: Valproic acid as a potential therapeutic drugZhuolin Wu, Zilin Zhao, Yang Li, et al.
Cancer Medicine|October 22, 2025
BTK Inhibitor Synergizes With CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients With Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic Clinical TrialWenjing Luo, Yinqiang Zhang, Chenggong Li, et al.
Cancer Management and Research|October 6, 2018
An expression signature model to predict lung adenocarcinoma-specific survivalXiaoshun Shi, Haoming Tan, Xiaobing Le, et al.
Frontiers in Molecular Neuroscience|January 28, 2026
Omaveloxolone promotes functional recovery of spinal cord injury by reducing inflammatory response and regulating macrophage polarizationPengtian Zhao, Wenlu Yuan, Jiayi Zhang, et al.
Cytotherapy|April 19, 2023
Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphomaWenjing Luo, Chenggong Li, Jianghua Wu, et al.
Pageof 4